Harsanyi Zsolt 4
4 · Aptevo Therapeutics Inc. · Filed Jun 3, 2022
Insider Transaction Report
Form 4
Harsanyi Zsolt
Director
Transactions
- Exercise/Conversion
Common Stock
2022-06-01+298→ 4,607 total - Exercise/Conversion
Restricted Stock Unit
2022-06-01−298→ 595 total→ Common Stock (298 underlying)
Footnotes (3)
- [F1]Restricted Stock Units ("RSUs") convert into common stock, $0.001 par value per share, of the Issuer on a one-for-one basis.
- [F2]Shares beneficially owned by the reporting person were adjusted to include the following shares of the Issuer's common stock: (i) 210 shares that were inadvertently omitted from the Form 4 filed on August 5, 2016; and (ii) 527 shares that were originally disclosed in the Form 4 filed on August 5, 2016, but due to a mathematical error, were not included in the aggregate number of shares beneficially owned in the Form 4 filed on June 7, 2019. In each of subsections (i) and (ii) above, the number of shares were adjusted to reflect a 1-for-14 reverse stock split of the Issuer's common stock effective as of March 26, 2020.
- [F3]On June 1, 2021, the reporting person was granted 893 RSUs, vesting in three approximately equal annual installments beginning on June 1, 2022.